Stay updated on Pembrolizumab Combo in Ovary Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Ovary Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Ovary Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and v3.4.1 removed; this is a minor UI revision with no impact on study content, eligibility, enrollment, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T12:39:00.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision: v3.4.1 is now shown, replacing v3.4.0. No study content or eligibility criteria appear to be changed.
    Difference
    0.0%
    Check dated 2026-02-05T13:23:19.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The changes add a Show glossary option and standardize metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0) while removing older labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4). These updates do not alter core study content, eligibility, or results, and to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-29T07:57:16.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Added related topics: Ovarian cancer and MedlinePlus Genetics to the page.
    Difference
    0.1%
    Check dated 2026-01-22T05:36:31.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4; removed related topics 'Ovarian cancer' and 'MedlinePlus Genetics', and removed 'Revision: v3.3.3'.
    Difference
    0.2%
    Check dated 2026-01-15T02:51:10.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    New Locations section added with Ohio and Wisconsin sites, replacing the previous separate Ohio Locations and Wisconsin Locations sections.
    Difference
    0.3%
    Check dated 2025-12-24T13:58:27.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Ovary Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Ovary Cancer Clinical Trial page.